Medline (Nasdaq:MDLN) has received a warning letter from the FDA related to NAMIC brand angiographic control syringes and ...
The U.S. FDA issued a warning letter to Medline Inc. having identified several issues with its Namic brand angiographic control syringes and manifolds used for the intra-arterial or intravenous ...
Months after the FDA warned clinicians about plastic syringes made in China, the agency listed violations it discovered at Cardinal Health related to the marketing of unapproved and adulterated ...
Designed for contrast media injections, the PowrSyringe is capable of an injection that is between 20 and 100% faster than a standard control syringe. Nothing beats the need for speed when it comes to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results